Neil Butt

Neil Butt is a seasoned Global Business Development Executive with a robust career spanning over 20 years. He has established himself as an expert in the biologic drug development industry, with extensive experience in commercializing novel and proprietary antibody engineering technologies, cell-line development, and cGMP manufacturing. Neil's skills include negotiating complex business deals, developing clear marketing strategies, and implementing plans for year on year growth. With a Ph.D. in Molecular Microbiology from the University of Southampton, Neil has a strong scientific background combined with executive management experience. Neil has been part of several successful business deals that have resulted in multimillion-dollar turn-over for the companies he has served, including selling two companies, acquiring two others, listing on the London Stock Exchange AIM market, and making multiple in-licensing deals. Neil's leadership, negotiation skills, and expertise in commercializing proprietary technologies have made him a respected name in the industry.